Streetbeat News

Revenues

CARS

Cars.com forecasts Q1 revenue of $179M-$181M, indicating a 7%-8% year-over-year growth, driven by Dealer revenue, the D2C acquisition, and the 2023 Marketplace Repackaging Initiative. OEM and National Advertising spend is expected to increase, with overall revenue growth guidance of 6%-8% for the year. Adjusted EBITDA margin is projected to be 27%-29% for Q1, with an expected improvement to 28%-30% for the full year, despite higher Q1 marketing and sales investments.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:33 pm

ITCI

Intra-Cellular Therapies projects its 2024 CAPLYTA net product sales to be between $645 million and $675 million.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:32 pm

LAUR

Laureate Education, Inc. (LAUR) provided its fiscal year 2024 outlook, projecting revenue between $1.553 billion and $1.568 billion, total enrollments between 467,000 and 473,000, and adjusted EBITDA between $441 million and $451 million. The company anticipates stronger growth in Mexico due to a positive macroeconomic environment, while expecting more muted growth in Peru due to the current economic downturn, with recovery anticipated in the second half of the year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:25 pm

LAUR

Laureate Education (NASDAQ:LAUR) reported Q4 2023 earnings of $0.26 per share with sales of $409.40M, surpassing the $388.00M estimate. This represents an 18.22% increase over the previous year's sales of $346.30M.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:17 pm

BHC

Bausch Health Companies projects its 2024 revenues to be between $9.3B and $9.55B, surpassing the consensus estimate of $8.97B. The company also forecasts its adjusted EBITDA to range from $3.20B to $3.35B.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:15 pm

NABL

N-able has updated its Q1 2024 financial outlook, expecting revenue between $111M-$111.5M, surpassing the $110.975M estimate, and adjusted EBITDA between $37.5M-$38M. This reflects an 11%-12% year-over-year growth and EBITDA representing about 34% of total revenue.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:14 pm

NABL

N-able projects FY24 revenue to be between $460M and $465M, slightly below the $465.39M estimate, with adjusted EBITDA expected to be between $158M and $162M, indicating a 9% to 11% year-over-year growth on a constant currency basis.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:13 pm

LNTH

Lantheus Holdings projects its Q1 revenues to be between $347M-$355M, surpassing the $336.41M estimate. The company also forecasts its Q1 adjusted EPS to range from $1.50-$1.54, closely aligning with the $1.51 estimate.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:13 pm

BHC

Bausch Health Companies reported Q4 sales of $2.41 billion, surpassing the $2.30 billion estimate, marking a 9.80% increase from last year's $2.19 billion. Adjusted net income was $406M.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:12 pm

BIGC

BigCommerce Holdings (BIGC) provided its Q1 and full year 2024 financial outlook, expecting Q1 revenue of $76.0M-$78.0M, below the $80.1M estimate, and FY24 revenue of $327.1M-$335.1M, below the $336.34M estimate. The company anticipates a year-over-year growth rate of 6% to 9% for Q1 and 6% to 8% for the full year, with non-GAAP operating income expected to be between $1.0M-$2.0M for Q1 and $8.5M-$12.5M for FY24.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:12 pm